Regulation_NN of_IN Airway_NP Tight_NP Junctions_NP by_IN Proinflammatory_NP Cytokines_NP Epithelial_NP tight_JJ junctions_NNS (_( TJs_NP )_) provide_VBP an_DT important_JJ route_NN for_IN passive_JJ electrolyte_NN transport_NN across_IN airway_NN epithelium_NN and_CC provide_VB a_DT barrier_NN to_TO the_DT migration_NN of_IN toxic_JJ materials_NNS from_IN the_DT lumen_NN to_TO the_DT interstitium_NN ._SENT The_DT possibility_NN that_IN TJ_NP function_NN may_MD be_VB perturbed_VBN by_IN airway_NN inflammation_NN originated_VBN from_IN studies_NNS reporting_VBG (_( 1_LS )_) increased_VBN levels_NNS of_IN the_DT proinflammatory_JJ cytokines_NNS interleukin-8_NN (_( IL-8_NP )_) ,_, tumor_NN necrosis_NN factor_NN alpha_NN (_( TNF-alpha_NP )_) ,_, interferon_NN gamma_NN (_( IFN-gamma_NP )_) ,_, and_CC IL-1beta_NP in_IN airway_NN epithelia_NNS and_CC secretions_NNS from_IN cystic_JJ fibrosis_NN (_( CF_NP )_) patients_NNS and_CC (_( 2_LS )_) abnormal_JJ TJ_NP strands_NNS of_IN CF_NP airways_NNS as_RB revealed_VBD by_IN freeze-fracture_NN electron_NN microscopy_NN ._SENT We_PP measured_VBD the_DT effects_NNS of_IN cytokine_NN exposure_NN of_IN CF_NP and_CC non-CF_NP well-differentiated_JJ primary_JJ human_JJ airway_NN epithelial_JJ cells_NNS on_IN TJ_NP properties_NNS ,_, including_VBG transepithelial_JJ resistance_NN ,_, paracellular_JJ permeability_NN to_TO hydrophilic_JJ solutes_NNS ,_, and_CC the_DT TJ_NP proteins_NNS occludin_NN ,_, claudin-1_JJ ,_, claudin-4_JJ ,_, junctional_JJ adhesion_NN molecule_NN ,_, and_CC ZO-1_NP ._SENT We_PP found_VBD that_IN whereas_IN IL-1beta_NP treatment_NN led_VBD to_TO alterations_NNS in_IN TJ_NP ion_NN selectivity_NN ,_, combined_JJ treatment_NN of_IN TNF-alpha_NP and_CC IFN-gamma_NP induced_VBD profound_JJ effects_NNS on_IN TJ_NP barrier_NN function_NN ,_, which_WDT could_MD be_VB blocked_VBN by_IN inhibitors_NNS of_IN protein_NN kinase_NN C._NP CF_NP bronchi_NNS in_IN vivo_RB exhibited_VBN the_DT same_JJ pattern_NN of_IN expression_NN of_IN TJ-associated_JJ proteins_NNS as_IN cultures_NNS exposed_VBN in_IN vitro_NN to_TO prolonged_JJ exposure_NN to_TO TNF-alpha_NP and_CC IFN-gamma_NP ._SENT These_DT data_NNS indicate_VBP that_IN the_DT TJ_NP of_IN airway_NN epithelia_NNS exposed_VBN to_TO chronic_JJ inflammation_NN may_MD exhibit_VB parallel_JJ changes_NNS in_IN the_DT barrier_NN function_NN to_TO both_DT solutes_NNS and_CC ions_NNS ._SENT Tight_JJ junctions_NNS (_( TJs_NP )_) are_VBP characteristically_RB located_VBN at_IN the_DT apicolateral_JJ borders_NNS of_IN adjacent_JJ epithelial_JJ cells_NNS and_CC are_VBP responsible_JJ for_IN the_DT selective_JJ regulation_NN of_IN the_DT passage_NN of_IN ions_NNS and_CC neutral_JJ molecules_NNS through_IN the_DT paracellular_JJ space_NN ._SENT In_IN addition_NN to_TO their_PP$ key_JJ role_NN in_IN maintaining_VBG barrier_NN function_NN of_IN the_DT epithelium_NN ,_, TJs_NNS have_VBP been_VBN implicated_VBN in_IN the_DT pathogenesis_NN of_IN several_JJ diseases_NNS ._SENT One_CD group_NN of_IN disorders_NNS ,_, inflammatory_JJ bowel_NN disease_NN ,_, displays_VBZ a_DT highly_RB deregulated_VBN barrier_NN function_NN that_WDT appears_VBZ to_TO be_VB a_DT fundamental_JJ event_NN in_IN disease_NN pathogenesis_NN ._SENT Whether_IN the_DT alteration_NN in_IN TJ_NP barrier_NN function_NN is_VBZ a_DT primary_JJ phenomenon_NN associated_VBN with_IN the_DT disease_NN or_CC an_DT acquired_VBN response_NN caused_VBN by_IN the_DT high_JJ degree_NN of_IN inflammation_NN associated_VBN with_IN the_DT disease_NN is_VBZ unclear_JJ ._SENT If_IN ,_, indeed_RB ,_, the_DT TJ_NP response_NN is_VBZ acquired_VBN ,_, this_DT would_MD suggest_VB that_IN other_JJ diseases_NNS known_VBN to_TO be_VB associated_VBN with_IN a_DT high_JJ level_NN of_IN inflammation_NN may_MD display_VB a_DT characteristic_JJ change_NN in_IN TJ_NP barrier_NN function_NN ._SENT Cystic_JJ fibrosis_NN (_( CF_NP )_) serves_VBZ as_IN an_DT excellent_JJ model_NN for_IN the_DT study_NN of_IN the_DT effects_NNS of_IN inflammation_NN on_IN TJ_NP barrier_NN function_NN ._SENT The_DT airway_NN disease_NN of_IN CF_NP is_VBZ characterized_VBN by_IN an_DT inflammatory_JJ response_NN with_IN a_DT marked_JJ influx_NN of_IN neutrophils_NNS and_CC chronic_JJ bacterial_JJ infection_NN with_IN Pseudomonas_NP aeruginosa_NP ._SENT Proinflammatory_JJ cytokines_NNS detected_VBN in_IN CF_NP airways_NNS serve_VBP in_IN part_NN to_TO perpetuate_VB this_DT inflammatory_JJ response_NN ._SENT High_JJ levels_NNS of_IN the_DT proinflammatory_JJ cytokines_NNS tumor_NN necrosis_NN factor_NN alpha_NN (_( TNF-alpha_NP )_) ,_, interleukin_NN (IL)-8_NN ,_, and_CC IL-1beta_NP as_RB well_RB as_IN the_DT soluble_JJ intercellular_JJ adhesion_NN molecule_NN (ICAM)-1_NN have_VBP been_VBN measured_VBN in_IN the_DT airways_NNS of_IN patients_NNS with_IN CF_NP ._SENT The_DT airway_NN epithelium_NN of_IN patients_NNS with_IN CF_NP also_RB expresses_VBZ an_DT increased_VBN level_NN of_IN signal_NN transducer_NN and_CC activator_NN of_IN transcription-1_JJ (_( STAT-1_NP )_) ,_, a_DT component_NN of_IN the_DT interferon_NN gamma_NN (_( IFN-gamma_NP )_) signaling_VBG cascade_NN ,_, indicating_VBG that_IN IFN-gamma_NP may_MD also_RB be_VB increased_VBN in_IN CF_NP airways_NNS ._SENT In_IN addition_NN ,_, increased_VBD levels_NNS of_IN IFN-gamma_NP mRNA_NP have_VBP also_RB been_VBN detected_VBN in_IN the_DT airway_NN epithelium_NN of_IN CF_NP patients_NNS ._SENT Freeze-fracture_NN electron_NN microscopy_NN (_( EM_NN )_) has_VBZ shown_VBN previously_RB that_IN the_DT TJ_NP strands_NNS of_IN inflamed_VBN CF_NP airways_NNS appear_VBP to_TO be_VB altered_VBN compared_VBN with_IN those_DT from_IN non-CF_NN patients_NNS ._SENT The_DT cytokines_NNS IL-1_JJ ,_, IL-4_NN ,_, IL-10_NP ,_, IL-13_NP ,_, TNF-alpha_NP ,_, and_CC IFN-gamma_NP have_VBP all_RB been_VBN shown_VBN to_TO regulate_VB the_DT TJ_NP of_IN both_DT epithelia_NN and_CC endothelia_NNS ._SENT In_IN addition_NN ,_, IL-1beta_NP has_VBZ been_VBN shown_VBN to_TO alter_VB TJ_NP permeability_NN through_IN an_DT effect_NN on_IN the_DT claudin_NN family_NN of_IN transmembrane_NN proteins_NNS thought_VBD to_TO be_VB important_JJ in_IN maintaining_VBG junctional_JJ integrity_NN in_IN astrocytes_NNS ._SENT However_RB ,_, these_DT studies_NNS have_VBP not_RB focused_VBN on_IN the_DT effects_NNS of_IN chronic_JJ cytokine_NN exposure_NN on_IN airway_NN epithelial_JJ TJ_NP function_NN ._SENT The_DT TJ_NP is_VBZ a_DT complex_JJ structure_NN composed_VBN of_IN several_JJ protein_NN components_NNS ,_, some_DT of_IN whose_WP$ function(s)_NNS remain_VBP largely_RB unclear_JJ ._SENT The_DT claudin_NN family_NN of_IN transmembrane_NN proteins_NNS are_VBP thought_VBN to_TO be_VB key_JJ components_NNS of_IN the_DT TJ_NP ,_, but_CC the_DT growing_VBG number_NN of_IN members_NNS of_IN this_DT family_NN impedes_VBZ a_DT complete_JJ understanding_NN of_IN their_PP$ function_NN ._SENT Several_JJ other_JJ components_NNS ,_, such_JJ as_IN occludin_NN ,_, junctional_JJ adhesion_NN molecule_NN (_( JAM_NP )_) ,_, and_CC more_RBR recently_RB the_DT coxsackievirus_NN and_CC adenovirus_NN 2/5_CD receptor_NN ,_, have_VBP been_VBN localized_VBN to_TO the_DT TJ_NP ._SENT Occludin_NN ,_, the_DT first_JJ transmembrane_NN TJ_NP protein_NN identified_VBD ,_, has_VBZ been_VBN localized_VBN to_TO the_DT TJ_NP strand_NN with_IN claudins_NNS ._SENT JAM_NN has_VBZ been_VBN identified_VBN as_IN a_DT component_NN of_IN the_DT TJ_NP necessary_JJ to_TO allow_VB the_DT transmigration_NN of_IN monocytes_NNS through_IN the_DT paracellular_JJ space_NN ,_, which_WDT makes_VBZ it_PP a_DT likely_JJ target_NN for_IN inflammation-induced_JJ alterations_NNS in_IN TJ_NP function_NN ._SENT Which_WDT of_IN these_DT components_NNS is_VBZ significant_JJ in_IN maintaining_VBG the_DT integrity_NN of_IN the_DT airway_NN TJ_NP during_IN inflammation_NN is_VBZ unknown_JJ ._SENT The_DT regulation_NN of_IN TJ_NP function_NN is_VBZ incompletely_RB understood_VBN and_CC may_MD vary_VB among_IN different_JJ cell_NN types_NNS ._SENT Several_JJ protein_NN kinase_NN C_NP (_( PKC_NP )_) isoforms_NNS have_VBP been_VBN associated_VBN with_IN changes_NNS in_IN paracellular_JJ permeability_NN ._SENT Previous_JJ studies_NNS have_VBP shown_VBN a_DT correlation_NN between_IN the_DT level_NN of_IN membrane-associated_JJ PKCalpha_NP and_CC the_DT extent_NN of_IN paracellular_JJ permeability_NN ,_, and_CC PKCbeta_NP has_VBZ been_VBN shown_VBN to_TO play_VB a_DT role_NN in_IN the_DT regulation_NN of_IN endothelial_JJ TJs_NP ._SENT In_IN addition_NN ,_, the_DT atypical_JJ PKC_NP isoforms_NP PKCzeta_NP have_VBP been_VBN localized_VBN to_TO the_DT TJ_NP of_IN MDCK_NP cells_NNS ._SENT Atypical_JJ PKC_NP isotype-specific_JJ interacting_VBG protein_NN may_MD also_RB localize_VB to_TO the_DT TJ_NP via_IN interactions_NNS with_IN PKCiota/lambda_NP and_CC PKCzeta_NP ,_, forming_VBG a_DT complex_NN that_WDT is_VBZ tethered_VBN to_TO the_DT junction_NN by_IN a_DT direct_JJ interaction_NN with_IN JAM_NP ._SENT Although_IN PKC_NP isoforms_NNS appear_VBP to_TO play_VB a_DT functional_JJ role_NN in_IN the_DT TJ_NP ,_, factors_NNS regulating_VBG their_PP$ expression_NN remain_VB unclear_JJ ,_, in_IN particular_JJ ,_, how_WRB these_DT isoforms_NNS are_VBP affected_VBN by_IN biological_JJ stimuli_NNS ,_, including_VBG inflammation_NN ._SENT The_DT difference_NN in_IN the_DT morphology_NN of_IN CF_NP airways_NNS as_RB determined_VBN by_IN freeze-fracture_NN EM_NN suggests_VBZ that_IN the_DT environment_NN of_IN the_DT CF_NP airway_NN might_MD lead_VB to_TO disruption_NN of_IN the_DT barrier_NN function_NN of_IN the_DT TJ_NP ._SENT To_TO determine_VB whether_IN the_DT chronic_JJ inflammation_NN of_IN CF_NP airways_NNS leads_VBZ to_TO modulation_NN of_IN airway_NN TJs_NNS ,_, we_PP exposed_VBD CF_NP and_CC non-CF_NN well-differentiated_VBN (_( WD_NP )_) primary_JJ human_JJ airway_NN epithelial_JJ (_( HAE_NP )_) cells_NNS to_TO cytokines_NNS that_WDT are_VBP upregulated_JJ in_IN CF_NP ,_, including_VBG IL-1beta_NP ,_, TNF-alpha_NP ,_, and_CC IFN-gamma_NP ._SENT We_PP then_RB assessed_VBD the_DT effects_NNS of_IN this_DT treatment_NN on_IN TJ_NP barrier_NN function_NN and_CC on_IN components_NNS of_IN the_DT TJ_NP ._SENT To_TO correlate_VB the_DT effects_NNS of_IN cytokines_NNS on_IN primary_JJ HAE_NP cells_NNS in_IN vitro_NN with_IN the_DT effects_NNS seen_VBN in_IN vivo_RB ,_, we_PP performed_VBD immunofluorescence_NN localization_NN of_IN TJ_NP components_NNS in_IN freshly_RB excised_VBN human_JJ CF_NP and_CC non-CF_NP large_JJ airways_NNS ._SENT Chemicals_NNS and_CC Antibodies_NNS |_SYM TNF-alpha_NP and_CC IFN-gamma_NP were_VBD purchased_VBN from_IN Sigma_NP Chemical_NP Inc._NP (_( St._NP Louis_NP ,_, MO_NP )_) ._SENT Rabbit_NN polyclonal_JJ antibodies_NNS to_TO ZO-1_NP ,_, claudin-1_JJ ,_, and_CC occludin_NN and_CC mouse_NN monoclonal_NN antibodies_NNS (_( mAbs_NNS )_) to_TO occludin_NN ,_, ZO-1_NP ,_, and_CC ICAM-1_NP were_VBD purchased_VBN from_IN Zymed_NP Laboratories_NPS (_( San_NP Francisco_NP ,_, CA_NP )_) ._SENT Rabbit_NN polyclonal_NN and_CC goat_NN polyclonal_JJ antibodies_NNS to_TO ICAM-1_NP were_VBD purchased_VBN from_IN Santa_NP Cruz_NP Biochemical_NP (_( Santa_NP Cruz_NP ,_, CA_NP )_) ._SENT The_DT 3D8_JJ mouse_NN mAb_NN to_TO JAM_NP was_VBD kindly_RB provided_VBN by_IN Dr._NP Kenji_NP Ishii_NP (_( Kyoto_NP ,_, Japan_NP )_) ._SENT Rabbit_NN polyclonal_JJ antibodies_NNS to_TO both_DT PKCiota/lambda_NP and_CC PKCzeta_NP were_VBD purchased_VBN from_IN Santa_NP Cruz_NP ._SENT The_DT mouse_NN anti-claudin-4_NN mAb_NN was_VBD generously_RB provided_VBN by_IN James_NP M._NP Anderson_NP (_( Yale_NP University_NP ,_, New_NP Haven_NP ,_, CT_NP )_) ._SENT The_DT FITC-conjugated_JJ dextrans_NNS were_VBD purchased_VBN from_IN Sigma_NP ._SENT The_DT PKC_NP inhibitor_NN H7_JJ and_CC the_DT tyrosine_NN kinase_NN inhibitor_NN genistein_NN were_VBD purchased_VBN from_IN Sigma_NP ._SENT Chelerythrine_NP chloride_NN was_VBD purchased_VBN from_IN Alexis_NP Corp._NP (_( San_NP Diego_NP ,_, CA_NP )_) ._SENT Cell_NN Culture_NP |_SYM Primary_JJ airway_NN cells_NNS from_IN human_JJ subjects_NNS were_VBD obtained_VBN in_IN accordance_NN with_IN guidelines_NNS approved_VBN by_IN the_DT Committee_NP on_IN the_DT Protection_NN of_IN the_DT Rights_NPS of_IN Human_NP Subjects_NP ._SENT Bronchial_JJ cells_NNS of_IN normal_JJ (_( non-CF_NN )_) and_CC CF_NP type_NN were_VBD isolated_VBN from_IN surgical_JJ specimens_NNS ,_, plated_VBN at_IN a_DT density_NN of_IN 2_CD x_SYM 105_CD cells/12-mm_NP Transwell-Col_NP (_( 0.4-mum_NN pore_NN size_NN )_) insert_NN ,_, and_CC maintained_VBD in_IN a_DT 50:50_CD mixture_NN of_IN LHC_NP Basal_NP Medium_NP (_( Biofluids_NP ,_, Rockville_NP ,_, MD_NP )_) and_CC DMEM-H_NP medium_NN supplemented_VBN with_IN growth_NN factors_NNS ,_, retinoic_JJ acid_NN ,_, and_CC BSA_NP as_RB previously_RB described_VBN ._SENT After_IN cultures_NNS reached_VBN confluence_NN ,_, medium_NN was_VBD aspirated_VBN from_IN the_DT apical_JJ surface_NN ,_, and_CC cells_NNS were_VBD maintained_VBN at_IN an_DT air-liquid_JJ interface_NN for_IN 4_CD wk_NN ._SENT Cultures_NNS with_IN 10_CD %_NN cilia_NNS as_RB determined_VBN by_IN microscopy_NN and_CC a_DT transepithelial_JJ resistance_NN (_( RT_NP )_) of_IN 600_CD Omega-cm2_NN measured_VBN with_IN an_DT ohmmeter_NN (_( EVOM_NP ;_: World_NP Precision_NP Instruments_NP ,_, Sarasota_NP ,_, FL_NP )_) were_VBD selected_VBN for_IN experiments_NNS ._SENT Cultures_NNS were_VBD exposed_VBN to_TO cytokines_NNS on_IN the_DT basolateral_JJ surface_NN for_IN 24_CD ,_, 48_CD ,_, or_CC 72_CD h._JJ Transepithelial_NP Cell_NP Permeability_NP |_SYM Permeation_NN of_IN FITC-dextrans_NP of_IN 10_CD and_CC 2000_CD kDa_NN across_IN primary_JJ HAE_NP cells_NNS was_VBD measured_VBN after_IN 24_CD ,_, 48_CD ,_, or_CC 72_CD h_NN exposure_NN to_TO cytokines_NNS ._SENT Compounds_NNS were_VBD added_VBN to_TO the_DT apical_JJ surface_NN (_( 200_CD muL_NN of_IN a_DT 5-mg/mL_JJ solution_NN in_IN HEPES-buffered_NP Ringer_NP 's_POS solution_NN containing_VBG 1.3_CD mM_NP CaCl2_NP )_) ,_, and_CC samples_NNS (_( 10_CD muL_NN )_) were_VBD removed_VBN from_IN the_DT apical_JJ and_CC basolateral_JJ compartments_NNS at_IN 10_CD ,_, 20_CD ,_, 30_CD ,_, 40_CD ,_, and_CC 60_CD min_NN ._SENT The_DT rate_NN of_IN permeation_NN was_VBD determined_VBN by_IN measuring_VBG the_DT sample_NN fluorescence_NN at_IN 496_CD nm_NN in_IN a_DT 96-well_NP fluorescent_JJ plate_NN reader_NN ._SENT The_DT paracellular_JJ permeability_NN to_TO hydrophilic_JJ solutes_NNS (_( Papp_NP )_) coefficients_NNS were_VBD calculated_VBN as_IN previously_RB described_VBN ._SENT Electrophysiological_JJ Measurements_NNS of_IN Dilution_NP Potential_JJ |_SYM Polarized_JJ CF_NP primary_JJ HAE_NP cultures_NNS were_VBD treated_VBN with_IN IL-1beta_NP for_IN 72_CD h_NN and_CC mounted_VBN in_IN modified_JJ Ussing_NP chambers_NNS interfaced_VBN with_IN an_DT electrometer_NN ,_, in_IN which_WDT transepithelial_JJ potential_JJ difference_NN (_( VT_NP )_) and_CC RT_NP were_VBD measured_VBN continuously_RB under_IN open-circuit_NN conditions_NNS ._SENT The_DT temperature_NN of_IN all_DT solutions_NNS was_VBD maintained_VBN at_IN 37C_JJ ,_, and_CC pH_NN was_VBD regulated_VBN by_IN bubbling_VBG with_IN 95_CD %_NN O2_NN --_: 5_CD %_NN CO2_NN ._SENT Basal_JJ VT_NP ,_, RT_NP ,_, and_CC current_JJ were_VBD recorded_VBN across_IN cultures_NNS in_IN a_DT buffer_NN containing_VBG high_JJ NaCl_NN (_( in_IN mM_NP :_: 120_CD NaCl_NN ,_, 10_CD HEPES_NNS at_IN pH_NN 7.4_CD ,_, 10_CD NaHCO3_NP ,_, 1.2_CD CaCl2_NP ,_, 5_CD KCl_NP ,_, and_CC 1_CD MgSO4_NN )_) and_CC 10-4_CD M_NN amiloride_NN ._SENT The_DT change_NN in_IN VT_NP (_( DeltaVT_NP )_) in_IN response_NN to_TO luminal_JJ substitution_NN with_IN a_DT buffer_NN containing_VBG low_JJ NaCl_NN (_( in_IN mM_NP :_: 60_CD NaCl_NN ,_, 120_CD mannitol_NN ,_, 10_CD HEPES_NNS at_IN pH_NN 7.4_CD ,_, 10_CD NaHCO3_NP ,_, 1.2_CD CaCl2_NP ,_, 5_CD KCl_NP ,_, and_CC 1_CD MgSO4_NN )_) and_CC 10-4_CD M_NP amiloride_NN was_VBD subsequently_RB recorded_VBN ._SENT Blank_JJ filters_NNS were_VBD used_VBN to_TO determine_VB background_NN and_CC subtracted_VBN from_IN subsequent_JJ measurements_NNS ._SENT Dilution_NN potentials_NNS (_( DeltaVT_NP )_) and_CC PCl-/PNa+_NP were_VBD calculated_VBN as_IN previously_RB described_VBN ._SENT All_DT measurements_NNS were_VBD performed_VBN in_IN a_DT minimum_NN of_IN six_CD total_JJ cultures_NNS isolated_VBN from_IN two_CD patients_NNS ._SENT Immunofluorescence_NP Labeling_NP and_CC Confocal_NP Microscopy_NP |_SYM Cells_NP were_VBD permeabilized_VBN with_IN methanol_NN at_IN -20C_NN for_IN 30_CD min_NN ._SENT Antibodies_NNS to_TO ZO-1_NP ,_, occludin_NP ,_, claudin-1_JJ ,_, claudin-4_NN ,_, PKCiota/lambda_NP ,_, and_CC JAM_NP diluted_VBD to_TO 1:1000_CD were_VBD added_VBN to_TO the_DT luminal_JJ surface_NN for_IN 1_CD h._NP Cells_NP were_VBD washed_VBN with_IN PBS_NP ,_, and_CC Texas_NP Red_NP --_: labeled_VBN secondary_JJ antibodies_NNS (_( Amersham_NP )_) ,_, diluted_VBD 1:600_CD in_IN 10_CD %_NN goat_NN serum/PBS_NNS ,_, were_VBD added_VBN to_TO the_DT luminal_JJ surface_NN ._SENT For_IN occludin_NN and_CC claudin-1_JJ double_JJ labeling_VBG ,_, a_DT mouse_NN mAb_NN to_TO occludin_NNS conjugated_VBN to_TO FITC_NP was_VBD incubated_VBN with_IN rabbit_NN polyclonal_JJ antibody_NN to_TO claudin-1_JJ and_CC incubated_VBN for_IN 1_CD h_NN at_IN room_NN temperature_NN ._SENT For_IN JAM_NP and_CC ZO-1_NP double_RB labeling_VBG ,_, 3D8_JJ mouse_NN anti-JAM_NN and_CC rabbit_NN anti-ZO-1_NN were_VBD added_VBN to_TO the_DT culture_NN ._SENT After_IN washing_NN ,_, anti-rabbit_JJ Texas_NP Red_NP and_CC antimouse_NP FITC_NP were_VBD incubated_VBN in_IN 10_CD %_NN goat_NN serum/PBS_NNS for_IN 1_CD h_NN at_IN room_NN temperature_NN ._SENT Cells_NNS were_VBD postfixed_VBN with_IN 4_CD %_NN paraformaldehyde_NN ._SENT Transwell-Col_NN inserts_NNS were_VBD excised_VBN and_CC mounted_VBN on_IN slides_NNS with_IN 100_CD muL_NN Vectashield_NP (_( Vector_NP Laboratories_NP ,_, Burlingame_NP ,_, CA_NP )_) containing_VBG 4',6-diamidino-2-phenylindole_JJ (_( DAPI_NP )_) ._SENT Images_NNS were_VBD captured_VBN with_IN a_DT confocal_JJ laser-scanning_NN microscope_NN (_( ,_, Exton_NP ,_, PA_NP )_) ._SENT Freshly_RB excised_VBN human_JJ bronchi_NNS from_IN non-CF_NP and_CC CF_NP (_( DeltaF/DeltaF_NP )_) subjects_NNS were_VBD embedded_VBN in_IN OCT_NP ,_, and_CC frozen_JJ sections_NNS (_( 10_CD mum_NN )_) were_VBD cut_VBN ._SENT Sections_NNS were_VBD incubated_VBN in_IN 95_CD %_NN ethanol_NN followed_VBN by_IN a_DT brief_JJ wash_NN in_IN PBS_NP ._SENT After_IN incubation_NN in_IN acetone_NN ,_, sections_NNS were_VBD washed_VBN in_IN 0.1_CD %_NN Triton_NP X-100_NP in_IN PBS_NP ,_, and_CC then_RB primary_JJ and_CC secondary_JJ antibodies_NNS added_VBD as_RB described_VBN above_IN ._SENT Western_NP Blotting_NP |_SYM Lysates_VBZ of_IN primary_JJ HAE_NP cells_NNS were_VBD prepared_VBN with_IN 0.1_CD %_NN Triton_NP X-100_NP extraction_NN buffer_NN containing_VBG phenylmethanesulfonyl_NN fluoride_NN (_( PMSF_NP )_) and_CC dithiothreitol_NP (_( DTT_NP )_) ._SENT Equal_JJ amounts_NNS of_IN protein_NN (_( 30_CD mug_NN )_) were_VBD loaded_VBN onto_IN Tris-glycine_NP gels_NNS (_( Novex_NP ,_, San_NP Diego_NP ,_, CA_NP )_) ._SENT After_IN electrophoresis_NN for_IN 1_CD h_NN at_IN 200_CD V_CD ,_, protein_NN was_VBD transferred_VBN to_TO nitrocellulose_NN or_CC polyvinylidine_NN difluoride_NN (_( PVDF_NP )_) membrane_NN at_IN 33_CD V_CD and_CC blocked_VBN in_IN 5_CD %_NN fat-free_JJ milk_NN ._SENT Membranes_NNS were_VBD probed_VBN at_IN antibody_NN dilutions_NNS of_IN 1:1000_CD in_IN Tris-buffered_JJ saline_NN --_: Tween-20_NP (_( TBS-T_NP )_) ._SENT Protein_NN was_VBD visualized_VBN with_IN a_DT peroxidase-conjugated_JJ secondary_JJ antibody_NN (_( 1:20,000_CD )_) by_IN enhanced_JJ chemiluminescence_NN (_( Amersham_NP Biosciences_NP ,_, Piscataway_NP ,_, NJ_NP )_) or_CC Supersignal_JJ west_JJ femto_NN maximum_NN sensitivity_NN substrate_NN for_IN JAM_NP blotting_VBG (_( ,_, Rockford_NP ,_, IL_NP )_) ._SENT For_IN immunoprecipitation_NN of_IN PKCiota/lambda_NP and_CC zeta_NN and_CC JAM_NP ,_, lysates_NNS were_VBD incubated_VBN with_IN rabbit_NN polyclonal_JJ antibodies_NNS to_TO PKCiota/lambda_NP or_CC zeta_NN or_CC mouse_NN mAb_NN to_TO JAM_NP for_IN 2_CD h_NN (_( PKC_NP )_) or_CC overnight_JJ (_( JAM_NP )_) at_IN 4C_JJ ,_, and_CC Sepharose_NP G_NP beads_NNS were_VBD added_VBN for_IN an_DT additional_JJ 1_CD h._NN After_IN centrifugation_NN ,_, beads_NNS were_VBD washed_VBN in_IN cell_NN lysis_NN buffer_NN and_CC then_RB heated_VBN at_IN 95C_NN for_IN 15_CD min_NN ._SENT Loading_NN buffer_NN was_VBD added_VBN and_CC Western_JJ blotting_VBG performed_VBN as_IN described_VBN above_IN ._SENT Blots_NNS were_VBD stripped_VBN with_IN Restore_NP Western_NP blot_NN stripping_VBG buffer_NN according_VBG to_TO the_DT manufacturer_NN 's_POS protocol_NN (_( Pierce_NP )_) ._SENT Human_JJ bronchi_NNS from_IN non-CF_NP and_CC CF_NP (_( DeltaF/DeltaF_NP )_) lungs_NNS were_VBD dissected_VBN immediately_RB after_IN removal_NN from_IN patients_NNS undergoing_VBG clinical_JJ lung_NN transplantation_NN (_( freshly_RB excised_VBN )_) and_CC placed_VBN in_IN ice-cold_JJ PBS_NP ,_, and_CC epithelium_NN was_VBD removed_VBN with_IN a_DT scalpel_NN ._SENT Protein_NN was_VBD isolated_VBN in_IN 7_CD M_NP urea_NN buffer_NN containing_VBG SDS_NP and_CC beta-mercaptoethanol_NN and_CC sonicated_JJ for_IN 30_CD s._JJ Protein_NP concentration_NN was_VBD determined_VBN with_IN the_DT RC/DC_NP Protein_NP Assay_NP (_( ,_, Hercules_NP ,_, CA_NP )_) ,_, 50_CD mug_NN total_JJ protein_NN run_VBN on_IN Tris-glycine_NP gels_NNS and_CC transferred_VBN to_TO PVDF_NP membrane_NN at_IN 33_CD V_CD for_IN 2_CD h._NP Western_NP blotting_VBG was_VBD performed_VBN as_IN described_VBN above_IN ._SENT For_IN Western_NP blotting_VBG of_IN JAM_NP ,_, membranes_NNS were_VBD incubated_VBN with_IN 3D8_JJ antibody_NN overnight_RB at_IN 4C_JJ ._SENT Occludin_NP Western_NP blotting_VBG was_VBD performed_VBN with_IN the_DT rabbit_NN polyclonal_JJ antibody_NN as_IN described_VBN above_IN ._SENT Densitometry_NN was_VBD performed_VBN with_IN Scion_NP Image_NP for_IN Windows_NP (_( Scion_NP ,_, Frederick_NP ,_, MD_NP )_) to_TO determine_VB average_JJ band_NN intensity_NN and_CC percent_NN difference_NN between_IN non-CF_NP and_CC CF_NP ._SENT The_DT intensity_NN of_IN lanes_NNS containing_VBG no_DT bands_NNS was_VBD set_VBN to_TO the_DT background_NN level_NN ._SENT RT-PCR_NP and_CC Quantitative_NP RT-PCR_NP |_SYM Total_JJ RNA_NP was_VBD isolated_VBN with_IN Qiagen_NP RNeasy_NP Protect_NP according_VBG to_TO the_DT manufacturer_NN 's_POS protocol_NN (_( Qiagen_NP ,_, Valencia_NP ,_, CA_NP )_) ._SENT RNA_NP was_VBD then_RB treated_VBN with_IN DNase_NP (_( Ambion_NP ,_, Austin_NP ,_, TX_NP )_) ._SENT For_IN complementary_JJ DNA_NN synthesis_NN ,_, 1_CD mug_NN total_JJ RNA_NP was_VBD used_VBN in_IN a_DT 20-muL_JJ reaction_NN containing_VBG 1_CD mM_NP deoxynucleotide_NN triphosphates_NNS (_( dNTPs_NNS )_) ,_, 2.5_CD mM_NP random_JJ hexamers_NNS or_CC oligo_NP dT_NP ,_, 1000_CD U/ml_NP RNase_NP inhibitor_NN ,_, 0.1_CD volume_NN 10X_NN buffer_NN (_( supplied_VBN by_IN manufacturer_NN )_) ,_, and_CC 2500_CD U/ml_NP murine_JJ leukemia_NN virus_NN reverse_NN transcriptase_NN (_( Invitrogen_NP ,_, Carlsbad_NP ,_, CA_NP )_) ._SENT The_DT reverse_JJ transcription_NN (_( RT_NP )_) reaction_NN was_VBD carried_VBN out_RP at_IN 1_CD cycle_NN in_IN a_DT thermal_JJ cycler_NN at_IN 42C_JJ for_IN 50_CD min_NN ,_, followed_VBN by_IN 15_CD min_NN incubation_NN at_IN 70C_NP ._SENT For_IN competitive_JJ quantitative_JJ RT-PCR_NP (_( cQRT-PCR_NN )_) ,_, an_DT internal_JJ standard_NN was_VBD generated_VBN containing_VBG a_DT 60-nucleotide_JJ deletion_NN that_WDT would_MD be_VB recognized_VBN by_IN the_DT same_JJ primers_NNS as_IN the_DT target_NN sequence_NN ._SENT RNA_NP for_IN this_DT internal_JJ standard_NN was_VBD generated_VBN by_IN ligation_NN of_IN a_DT T7_JJ promoter_NN followed_VBN by_IN in_IN vitro_NN transcription_NN ._SENT Before_IN RT_NP ,_, the_DT standard_NN was_VBD added_VBN at_IN a_DT concentration_NN range_NN of_IN 0.0001_CD to_TO 1_CD ng_NNS ,_, and_CC cDNA_NN was_VBD generated_VBN ._SENT For_IN semiquantitative_JJ RT-PCR_NP (_( QRT-PCR_NP )_) ,_, primers_NNS to_TO the_DT gene_NN of_IN interest_NN and_CC those_DT to_TO GAPDH_NP were_VBD added_VBN simultaneously_RB to_TO the_DT PCR_NP reaction_NN ._SENT PCR_NP was_VBD carried_VBN out_RP with_IN Taq_NP DNA_NP polymerase_NN for_IN 25_CD cycles_NNS ._SENT PCR_NP products_NNS were_VBD separated_VBN on_IN a_DT 1.5_CD %_NN agarose_NN gel_NN containing_VBG ethidium_NN bromide_NN ._SENT The_DT relative_JJ band_NN intensities_NNS were_VBD then_RB determined_VBN with_IN Scion_NP Image_NP ,_, and_CC the_DT amount_NN of_IN JAM_NP mRNA_NP expression_NN was_VBD calculated_VBN as_IN previously_RB described_VBN ._SENT The_DT amount_NN of_IN standard_NN added_VBD to_TO the_DT reaction_NN (_( in_IN ng_NNS )_) versus_IN the_DT ratio_NN of_IN standard_JJ (_( DeltaJAM_NP )_) to_TO transcript_NN was_VBD plotted_VBN on_IN a_DT double_JJ logarithmic_JJ plot_NN ._SENT The_DT amount_NN of_IN transcript_NN was_VBD then_RB determined_VBN by_IN measuring_VBG the_DT point_NN on_IN the_DT plot_NN at_IN which_WDT the_DT y-intercept_JJ equals_NNS 1_CD ,_, indicating_VBG an_DT equal_JJ ratio_NN of_IN standard_NN to_TO transcript_NN ,_, and_CC then_RB calculating_VBG the_DT x-intercept_NN ._SENT Enzyme-linked_JJ Immunosorbent_NP Assay_NP |_SYM Primary_JJ HAE_NP cells_NNS were_VBD treated_VBN with_IN cytokines_NNS for_IN 24_CD ,_, 48_CD ,_, or_CC 72_CD h_NN ,_, and_CC total_JJ protein_NN was_VBD isolated_VBN as_IN described_VBN above_IN ._SENT For_IN ICAM-1_NP ,_, a_DT 96-well_NP assay_NN plate_NN was_VBD coated_VBN overnight_RB with_IN mouse_NN monoclonal_NN ICAM-1_NP ,_, then_RB lysate_NNS was_VBD added_VBN at_IN 1_CD ,_, 3_CD ,_, and_CC 10_CD mug_NN and_CC incubated_VBN for_IN 2_CD h._NN After_IN washing_NN ,_, rabbit_NN polyclonal_JJ anti-ICAM-1_NN was_VBD added_VBN for_IN 2_CD h_NN ,_, followed_VBN by_IN horseradish_NN peroxidase_NN (HRP)-labeled_VBD secondary_JJ antibody_NN ._SENT For_IN JAM_NP ,_, plates_NNS were_VBD coated_VBN overnight_RB with_IN 1_CD ,_, 3_CD ,_, 10_CD ,_, or_CC 30_CD mug_NN lysate_NNS and_CC incubated_VBN with_IN mouse_NN monoclonal_NN anti-JAM_NN (_( 3D8_JJ )_) for_IN 2_CD h_NN and_CC visualized_VBN with_IN antimouse_NP HRP_NP ._SENT Protein_NN was_VBD detected_VBN by_IN addition_NN of_IN a_DT 1:1_CD ratio_NN of_IN H2O2:tetramethylbenzidine_NP ._SENT Optical_JJ density_NN was_VBD determined_VBN at_IN 450_CD nm_NN ._SENT Data_NNS are_VBP expressed_VBN as_IN percent_NN change_NN in_IN JAM_NP or_CC ICAM-1_NP relative_JJ to_TO vehicle_NN controls_NNS ._SENT Freeze-Fracture_NP EM_NP |_SYM Cultures_NP treated_VBN with_IN vehicle_NN or_CC cytokines_NNS were_VBD fixed_VBN in_IN 2_CD %_NN glutaraldehyde/2_JJ %_NN paraformaldehyde_NN in_IN 0.1_CD M_NP phosphate_NN buffer_NN (_( pH_NN 7.2_CD )_) at_IN 4C_JJ overnight_JJ ._SENT The_DT epithelium_NN was_VBD gently_RB removed_VBN from_IN the_DT Transwell-Col_NN with_IN a_DT scalpel_NN and_CC rinsed_VBN in_IN phosphate_NN buffer_NN containing_VBG 0.2_CD M_NN sucrose_NN at_IN room_NN temperature_NN ,_, followed_VBN by_IN a_DT 25_CD %_NN glycerol_NN cryoprotectant_NN solution_NN ._SENT The_DT epithelium_NN was_VBD sandwiched_VBN between_IN gold_JJ double-replica_NN mounts_NNS and_CC frozen_VBN in_IN liquid_JJ nitrogen_NN --_: cooled_VBN Freon_NN ._SENT Specimens_NNS were_VBD fractured_VBN in_IN a_DT Balzers_NP BAF_NP 400T_JJ freeze-fracture_NN plant_NN at_IN a_DT stage_NN temperature_NN of_IN -100C_NN ,_, and_CC replicas_NNS were_VBD made_VBN at_IN a_DT 30o_JJ angle_NN with_IN platinum/carbon_NN shadowing_VBG ._SENT The_DT replicas_NNS and_CC adherent_JJ tissue_NN were_VBD removed_VBN by_IN placing_VBG in_IN distilled_JJ water_NN ,_, followed_VBN by_IN transferring_VBG to_TO a_DT solution_NN of_IN 5_CD %_NN sodium_NN dichromate_NN in_IN 50_CD %_NN sulfuric_JJ acid_NN for_IN cleaning_NN ._SENT Replicas_NNS were_VBD then_RB moved_VBN again_RB to_TO distilled_JJ water_NN ,_, where_WRB they_PP were_VBD retrieved_VBN and_CC placed_VBN onto_IN standard_JJ copper_NN microscopy_NN grids_NNS ._SENT The_DT replicas_NNS were_VBD examined_VBN ,_, and_CC fields_NNS exhibiting_VBG TJs_NP at_IN a_DT plate_NN magnification_NN of_IN 20,000x_NP were_VBD photographed_VBN with_IN a_DT Zeiss_NP EM-10A_NP at_IN an_DT accelerating_JJ voltage_NN of_IN 60_CD kV_NN ._SENT Morphometric_JJ analysis_NN of_IN TJ_NP strands_NNS was_VBD performed_VBN as_IN previously_RB described_VBN ._SENT Photomicrographs_NNS were_VBD enlarged_VBN to_TO a_DT final_JJ magnification_NN of_IN 60,000x_NP ,_, and_CC TJs_NP were_VBD transected_VBN by_IN lines_NNS perpendicular_JJ to_TO the_DT luminal_JJ border_NN with_IN adjacent_JJ transects_VBZ no_RB closer_JJR than_IN 1_CD mum_NN apart_RB ._SENT Strand_NP depth_NN was_VBD calculated_VBN at_IN the_DT transected_VBN lines_NNS by_IN measuring_VBG the_DT distance_NN from_IN the_DT most_RBS luminal_JJ strand_NN to_TO the_DT most_RBS distal_JJ strand_NN ._SENT Statistics_NPS |_SYM Data_NP are_VBP presented_VBN as_IN mean_JJ +-_NN SEM_NP ._SENT A_DT one-way_JJ analysis_NN of_IN variance_NN (_( ANOVA_NP )_) and_CC Bonferroni_NP 's_POS correction_NN for_IN multiple_JJ comparisons_NNS were_VBD used_VBN to_TO determine_VB statistical_JJ significance_NN (_( p_NN <_SYM 0.05_CD )_) ._SENT Effect_NN of_IN Cytokine_NP Treatment_NP on_IN RT_NP and_CC Papp_NP |_SYM WD_JJ primary_JJ HAE_NP cells_NNS of_IN non-CF_NP and_CC CF_NP types_NNS were_VBD exposed_VBN to_TO cytokines_NNS involved_VBN in_IN CF_NP inflammation_NN ,_, IL-1beta_NP ,_, IFN-gamma_NP ,_, and_CC TNF-alpha_NP ._SENT To_TO determine_VB whether_IN treatment_NN with_IN either_DT cytokine_NN could_MD elicit_VB effects_NNS on_IN airway_NN TJ_NP permeability_NN ,_, we_PP exposed_VBD the_DT basolateral_JJ surface_NN of_IN HAE_NP cells_NNS to_TO IL-1beta_NP (_( 100_CD ng/ml_NNS )_) ,_, TNF-alpha_NP (_( 10_CD ng/ml_NNS )_) ,_, or_CC IFN-gamma_NP (_( 100_CD ng/ml_NNS )_) alone_RB or_CC in_IN combination_NN and_CC determined_VBD the_DT effects_NNS on_IN RT_NP and_CC Papp_NP at_IN 24_CD ,_, 48_CD ,_, and_CC 72_CD h._NN These_DT concentrations_NNS were_VBD chosen_VBN because_IN they_PP are_VBP similar_JJ to_TO levels_NNS detected_VBN in_IN the_DT airways_NNS of_IN CF_NP patients_NNS ._SENT After_IN 24_CD h_NN exposure_NN of_IN non-CF_NP WD_NP HAE_NP to_TO IL-1beta_NP ,_, TNF-alpha_NP ,_, or_CC IFN-gamma_NP alone_RB ,_, there_EX were_VBD no_DT significant_JJ effects_NNS on_IN Rt_NP ._SENT However_RB ,_, in_IN cultures_NNS exposed_VBN to_TO combined_JJ treatment_NN of_IN TNF-alpha_NP and_CC IFN-gamma_NP ,_, RT_NP at_IN 24_CD h_NN decreased_VBD to_TO 65_CD %_NN of_IN control_NN (_( vehicle-treated_JJ )_) cultures_NNS (_( Figure_NP A_NP )_) ._SENT After_IN 48_CD h_NN exposure_NN ,_, cultures_NNS exposed_VBN to_TO IFN-gamma_NP alone_RB exhibited_VBD RT_NP values_NNS that_WDT were_VBD 80_CD %_NN of_IN vehicle_NN cultures_NNS ,_, whereas_IN RT_NP in_IN those_DT exposed_VBN to_TO TNF-alpha_NP or_CC IL-1beta_NP alone_RB decreased_VBD to_TO 60_CD %_NN ._SENT The_DT RT_NP of_IN HAE_NP cells_NNS treated_VBN with_IN a_DT combination_NN of_IN TNF-alpha_NP and_CC IFN-gamma_NP decreased_VBD to_TO 30_CD %_NN of_IN control_NN cultures_NNS (_( Figure_NP A_NP )_) ._SENT The_DT effect_NN of_IN cytokines_NNS on_IN RT_NP was_VBD even_RB more_RBR dramatic_JJ after_IN 72_CD h_NN exposure_NN ,_, with_IN RT_NP of_IN cultures_NNS treated_VBN with_IN TNF-alpha_NP and_CC IFN-gamma_NP in_IN combination_NN falling_VBG to_TO 8_CD %_NN of_IN control_NN cultures_NNS (_( Figure_NP A_NP )_) ,_, whereas_IN exposure_NN to_TO IL-1beta_NP ,_, TNF-alpha_NP ,_, or_CC IFN-gamma_NP alone_RB decreased_VBD RT_NP to_TO similar60_JJ %_NN of_IN vehicle_NN controls_NNS ._SENT Exposure_NN of_IN cultures_NNS with_IN TNF-alpha_NP ,_, IFN-gamma_NP ,_, and_CC IL-1beta_NP simultaneously_RB did_VBD not_RB alter_VB the_DT kinetics_NN or_CC magnitude_NN of_IN either_DT RT_NP or_CC Papp_NP (_( data_NN not_RB shown_VBN )_) ._SENT Upon_IN removal_NN of_IN cytokines_NNS at_IN 72_CD h_NN ,_, RT_NP returned_VBD to_TO control_VB levels_NNS by_IN 24_CD h_NN posttreatment_NN (_( Figure_NP B_NP )_) ._SENT Figure_NP 1_CD |_SYM Effect_NN of_IN cytokines_NNS on_IN RT_NP ._SENT Effect_NN of_IN cytokines_NNS on_IN RT_NP ._SENT (_( A_NP )_) RT_NP of_IN non-CF_NP WD_NP primary_JJ HAE_NP cells_NNS exposed_VBN to_TO TNF-alpha_NP ,_, IFN-gamma_NP ,_, or_CC IL-1beta_NP alone_RB ,_, or_CC TNF-alpha_NP and_CC IFN-gamma_NP in_IN combination_NN ._SENT (_( B_NP )_) Recovery_NP of_IN RT_NP after_IN removal_NN of_IN TNF-alpha_NP and_CC IFN-gamma_NP at_IN 4_CD ,_, 12_CD ,_, and_CC 24_CD h_NN after_IN washing_NN ._SENT (_( C_NP )_) Effect_NN of_IN combined_JJ TNF-alpha_NP and_CC IFN-gamma_NP treatment_NN on_IN RT_NP in_IN non-CF_NP and_CC CF_NP primary_JJ HAE_NP cells_NNS ._SENT (_( D_NP )_) Effect_NN of_IN IL-1beta_NP on_IN RT_NP in_IN non-CF_NP and_CC CF_NP primary_JJ HAE_NP cells_NNS ._SENT *Significantly_RB different_JJ from_IN (_( A_NP )_) vehicle_NN and_CC TNF-alpha_NP ,_, IFN-gamma_NP ,_, or_CC IL-1beta_NP alone_RB or_CC from_IN (_( C_NP )_) non-CF_NN controls_NNS ,_, at_IN p_NN <_SYM 0.001_CD ._SENT Data_NNS presented_VBN are_VBP a_DT minimum_NN of_IN n_NN =_SYM 12_CD cultures_NNS from_IN at_IN least_JJS three_CD patients_NNS ._SENT CF_NP cultures_NNS displayed_VBD a_DT different_JJ kinetic_JJ profile_NN of_IN cytokine-induced_JJ changes_NNS in_IN RT_NP than_IN did_VBD non-CF_NN cultures_NNS ._SENT Whereas_IN the_DT RT_NP of_IN non-CF_NN cultures_NNS was_VBD only_RB modestly_RB affected_VBN by_IN cytokine_JJ treatment_NN at_IN 24_CD h_NN (_( 61_CD %_NN of_IN vehicle_NN )_) ,_, the_DT RT_NP of_IN CF_NP cultures_NNS exposed_VBN to_TO combined_JJ TNF-alpha_NP and_CC IFN-gamma_NP treatment_NN was_VBD reduced_VBN to_TO 18_CD %_NN of_IN vehicle-treated_JJ controls_NNS (_( Figure_NP C_NP )_) ._SENT This_DT trend_NN continued_VBD after_IN 48_CD h_NN exposure_NN ,_, with_IN RT_NP in_IN non-CF_NP cultures_NNS reduced_VBD to_TO 32_CD %_NN ,_, compared_VBN with_IN 10_CD %_NN of_IN vehicle_NN controls_NNS in_IN CF_NP cultures_NNS ._SENT However_RB ,_, by_IN 72_CD h_NN exposure_NN ,_, the_DT RT_NP in_IN both_DT non-CF_NP and_CC CF_NP cultures_NNS was_VBD reduced_VBN to_TO 5_CD --_: 10_CD %_NN of_IN vehicle_NN controls_NNS (_( Figure_NP C_NP )_) ._SENT In_IN contrast_NN ,_, there_EX was_VBD no_DT significant_JJ difference_NN between_IN non-CF_NP and_CC CF_NP cultures_NNS after_IN exposure_NN to_TO IL-1beta_NP at_IN any_DT time_NN point_NN (_( Figure_NP D_NP )_) ._SENT To_TO correlate_VB the_DT changes_NNS in_IN RT_NP induced_VBD after_IN cytokine_NN exposure_NN to_TO alterations_NNS in_IN the_DT barrier_NN function_NN of_IN the_DT TJ_NP ,_, the_DT permeability_NN coefficients_NNS of_IN cultures_NNS to_TO both_CC a_DT small_JJ solute_NN ,_, a_DT 10-kDa_NP FITC-labeled_NP dextran_NN ,_, and_CC a_DT larger_JJR solute_NN ,_, 2000-kDa_JJ FITC-labeled_JJ dextran_NN ,_, were_VBD measured_VBN after_IN cytokine_NN exposure_NN ._SENT In_IN non-CF_NN cultures_NNS ,_, there_EX was_VBD no_DT difference_NN in_IN the_DT Papp_NP to_TO the_DT 10-_CD and_CC 2000-kDa_JJ dextrans_NNS by_IN 24_CD h_NN (_( Figure_NP ,_, A_NP and_CC B_NP )_) in_IN cultures_NNS treated_VBN with_IN TNF-alpha_NP and_CC IFN-gamma_NP in_IN combination_NN ._SENT However_RB ,_, pronounced_JJ increases_NNS in_IN Papp_NP after_IN 48_CD and_CC 72_CD h_NN exposure_NN were_VBD detected_VBN ._SENT The_DT Papp_NP to_TO the_DT 10-kDa_NP dextran_NN increased_VBD by_IN 8-fold_NN and_CC that_IN to_TO the_DT 2000-kDa_JJ 19-fold_NN when_WRB treated_VBN with_IN TNF-alpha_NP and_CC IFN-gamma_NP in_IN combination_NN for_IN 48_CD h._NN By_IN 72_CD h_NN after_IN treatment_NN ,_, Papp_NP to_TO the_DT 10-kDa_NP dextran_NN was_VBD increased_VBN 17-fold_NN and_CC that_IN to_TO the_DT 2000-kDa_JJ dextran_NN 25-fold_NN (_( Figure_NP ,_, A_NP and_CC B_NP ,_, respectively_RB )_) ._SENT There_EX were_VBD no_DT differences_NNS in_IN the_DT Papp_NP between_IN cultures_NNS treated_VBN with_IN vehicle_NN and_CC those_DT treated_VBN with_IN IL-1beta_NP alone_RB at_IN any_DT time_NN point_NN (_( Figure_NP ,_, A_NP and_CC B_NP )_) ._SENT There_EX was_VBD also_RB no_DT difference_NN in_IN cultures_NNS exposed_VBN to_TO TNF-alpha_NP or_CC IFN-gamma_NP alone_RB (_( data_NNS not_RB shown_VBN )_) ._SENT To_TO provide_VB evidence_NN that_IN cytokines_NNS were_VBD increasing_VBG Papp_NP via_IN passive_JJ mechanisms_NNS typical_JJ of_IN the_DT paracellular_JJ route_NN ,_, the_DT permeability_NN to_TO solutes_NNS from_IN the_DT basolateral_NN to_TO apical_JJ compartments_NNS were_VBD measured_VBN and_CC were_VBD equal_JJ to_TO those_DT from_IN the_DT apical_JJ to_TO basolateral_JJ compartments_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Figure_NP 2_CD |_SYM Effect_NN of_IN cytokines_NNS on_IN Papp_NP ._SENT Effect_NN of_IN cytokines_NNS on_IN Papp_NP ._SENT Papp_NP to_TO (_( A_NP )_) 10-kDa_NP or_CC (_( B_NP )_) 2000-kDa_JJ FITC-labeled_JJ dextran_NN in_IN WD_JJ primary_JJ HAE_NNS exposed_VBN to_TO IL-1beta_NP alone_RB or_CC TNF-alpha_NP and_CC IFN-gamma_NP in_IN combination_NN for_IN 24_CD ,_, 48_CD ,_, or_CC 72_CD h._NN (_( C_NP ,_, D_NP )_) Comparison_NN of_IN the_DT effects_NNS of_IN TNF-alpha_NP and_CC IFN-gamma_NP combined_JJ treatment_NN on_IN Papp_NP in_IN non-CF_NP vs._CC CF_NP WD_NP primary_JJ HAE_NP cells_NNS to_TO (_( C_NP )_) 10-kDa_NP or_CC (_( D_NP )_) 2000-kDa_NP FITC-labeled_NP dextran_NN ._SENT *Significantly_RB different_JJ from_IN vehicle_NN (_( A_NP ,_, B_NP )_) or_CC from_IN non-CF_NP (_( C_NP ,_, D_NP )_) controls_VBZ at_IN p_NN <_SYM 0.05_CD ._SENT Data_NNS presented_VBN are_VBP a_DT minimum_NN of_IN n_NN =_SYM 12_CD cultures_NNS from_IN at_IN least_JJS three_CD patients_NNS ._SENT The_DT kinetics_NN of_IN the_DT changes_NNS in_IN Papp_NP of_IN CF_NP cultures_NNS treated_VBN with_IN TNF-alpha_NP and_CC IFN-gamma_NP in_IN combination_NN were_VBD more_RBR significant_JJ than_IN those_DT of_IN non-CF_NN cultures_NNS ._SENT After_IN 24_CD h_NN exposure_NN ,_, Papp_NP of_IN CF_NP cultures_NNS was_VBD 10-fold_NN greater_JJR than_IN both_DT vehicle-control_NN and_CC non-CF_NN cultures_NNS ._SENT At_IN 48_CD h_NN ,_, the_DT Papps_NP of_IN CF_NP cultures_NNS were_VBD similartwofold_RB greater_JJR than_IN those_DT of_IN non-CF_NN cultures_NNS ._SENT However_RB ,_, like_IN RT_NP ,_, Papp_NP after_IN 72_CD h_NN exposure_NN was_VBD equal_JJ between_IN non-CF_NP and_CC CF_NP cultures_NNS (_( Figure_NP C_NP )_) ._SENT In_IN addition_NN ,_, Papp_NP to_TO the_DT 2000-kDa_JJ dextran_NN was_VBD also_RB significantly_RB increased_VBN in_IN CF_NP versus_CC non-CF_NP cultures_NNS (_( Figure_NP D_NP )_) ._SENT Although_IN there_EX was_VBD no_DT increase_NN in_IN Papp_NP in_IN non-CF_NN cultures_NNS after_IN 24_CD h_NN ,_, there_EX was_VBD a_DT fivefold_JJ increase_NN in_IN CF_NP cultures_NNS ._SENT In_IN addition_NN ,_, at_IN 48_CD and_CC 72_CD h_NN ,_, there_EX is_VBZ an_DT similar1.5-fold_NN greater_JJR increase_NN in_IN Papp_NP of_IN CF_NP cultures_NNS than_IN non-CF_NP (_( Figure_NP D_NP )_) ._SENT IL-1beta_NP Effects_NP on_IN Na+_NP and_CC Cl-_NP Permeability_NP |_SYM Because_IN treatment_NN of_IN primary_JJ HAE_NP cells_NNS with_IN IL-1beta_NP did_VBD not_RB induce_VB alterations_NNS in_IN Papp_NP to_TO dextrans_NNS but_CC did_VBD lead_VB to_TO a_DT modest_JJ decrease_NN in_IN RT_NP ,_, we_PP evaluated_VBD more_JJR subtle_JJ effects_NNS on_IN TJ_NP function_NN by_IN measuring_VBG the_DT relative_JJ ion_NN selectivity_NN of_IN the_DT paracellular_JJ path_NN in_IN CF_NP cultures_NNS at_IN 72_CD h_NN after_IN IL-1beta_NP exposure_NN ._SENT The_DT effect_NN of_IN NaCl_NP ion_NN substitution_NN on_IN the_DT transepithelial_JJ dilution_NN potentials_NNS were_VBD determined_VBN and_CC used_VBN to_TO calculate_VB the_DT ratio_NN of_IN the_DT relative_JJ permeabilities_NNS of_IN Cl-_NP to_TO Na+_NP (_( PCl-/PNa+_NP )_) ._SENT To_TO exclude_VB ion_NN permeation_NN via_IN the_DT transcellular_JJ pathway_NN ,_, experiments_NNS were_VBD performed_VBN in_IN CF_NP cultures_NNS that_WDT do_VBP not_RB express_VB the_DT CF_NP transmembrane_NN conductance_NN regulator_NN (_( CFTR_NP )_) channel_NN on_IN the_DT apical_JJ membrane_NN ,_, thereby_RB excluding_VBG Cl-_NP permeation_NN via_IN the_DT transcellular_JJ route_NN ._SENT To_TO block_VB Na+_NP transcellular_JJ permeation_NN ,_, all_DT luminal_JJ solutions_NNS contained_VBD amiloride_NN (_( 10-4_CD M_NN )_) ._SENT Cultures_NNS treated_VBN with_IN IL-1beta_NP relative_JJ to_TO vehicle_NN exhibited_VBD a_DT decrease_NN in_IN DeltaVT_NP in_IN response_NN to_TO dilute_VB NaCl_NP solutions_NNS from_IN 9.00_CD +-_NN 0.28_CD mV_NN (_( vehicle_NN )_) to_TO 3.50_CD +-_NN 0.30_CD mV_NN (_( IL-1beta_NP )_) ,_, indicating_VBG an_DT effect_NN on_IN ion_NN permeation_NN ._SENT This_DT reduction_NN in_IN DeltaVT_NP correlated_VBD with_IN an_DT increase_NN in_IN PCl-/PNa+_NP in_IN cultures_NNS exposed_VBN to_TO IL-1beta_NP for_IN 72_CD h_NN ,_, from_IN 0.29_CD +-_NN 0.03_CD to_TO 0.73_CD +-_NN 0.30_CD ._SENT The_DT twofold_JJ increase_NN in_IN PCl-/PNa+_NP in_IN IL-1beta_NP --_: treated_VBN cultures_NNS also_RB correlated_VBN with_IN a_DT similartwofold_JJ increase_NN in_IN conductance_NN (_( GT_NP )_) ,_, an_DT increase_NN from_IN 1.20_CD +-_NN 0.20_CD mS/cm2_NN (_( vehicle_NN )_) to_TO 2.43_CD +-_NN 0.13_CD mS/cm2_NN (_( IL-1beta_NP )_) ._SENT Because_IN IL-1beta_NP led_VBD to_TO increased_VBN GT_NP and_CC a_DT hyperpolarization_NN of_IN VT_NP while_IN exhibiting_VBG a_DT net_JJ increase_NN in_IN PCl-/PNa+_NP ,_, it_PP can_MD be_VB concluded_VBN that_IN IL-1beta_NP leads_VBZ to_TO a_DT selective_JJ increase_NN in_IN paracellular_JJ permeability_NN to_TO Cl-_NP ._SENT Figure_NP 3_CD |_SYM Effect_NN of_IN IL-1beta_NP on_IN relative_JJ ion_NN selectivity_NN ._SENT Effect_NN of_IN IL-1beta_NP on_IN relative_JJ ion_NN selectivity_NN ._SENT Polarized_VBN CF_NP WD_NP primary_JJ HAE_NP cells_NNS were_VBD exposed_VBN to_TO IL-1beta_NP for_IN 72_CD h._JJ Electrophysiological_JJ measurements_NNS and_CC dilution_NN potential_NN (_( DeltaVT_NP )_) were_VBD measured_VBN and_CC permeability_NN ratio_NN of_IN Cl-/Na+_NP (_( PCl-/PNa+_NP )_) calculated_VBD as_RB described_VBN in_IN MATERIALS_NP AND_CC METHODS_NP ._SENT Shown_VBN are_VBP the_DT transepithelial_JJ voltage_NN recordings_NNS with_IN intermittent_JJ current_JJ pulses_NNS in_IN amiloride_NN (Amil)-treated_JJ cultures_NNS before_IN and_CC after_IN luminal_JJ substitution_NN with_IN a_DT low-NaCl_NN solution_NN ._SENT Current_JJ pulses_NNS and_CC voltage_NN scales_NNS are_VBP the_DT same_JJ ._SENT Summary_NN data_NNS are_VBP presented_VBN in_IN the_DT table_NN ._SENT Data_NNS presented_VBN are_VBP representative_JJ of_IN recordings_NNS from_IN 12_CD cultures_NNS from_IN 2_CD patients_NNS ._SENT *Significantly_RB different_JJ from_IN vehicle-treated_JJ controls_NNS ._SENT Cytokines_NP and_CC TJ_NP Morphology_NP |_SYM To_TO determine_VB whether_IN the_DT effects_NNS of_IN TNF-alpha_NP and_CC IFN-gamma_NP cotreatment_NN on_IN the_DT distribution_NN of_IN TJ_NP proteins_NNS also_RB affected_VBD the_DT morphology_NN of_IN TJ_NP strands_NNS ,_, we_PP performed_VBD freeze-fracture_NN EM_NNS and_CC quantified_VBD the_DT effect_NN of_IN cytokine_NN treatment_NN on_IN junctional_JJ depth_NN and_CC strand_NN number_NN ._SENT Freeze_NN fracture_NN splits_VBZ the_DT cell_NN membrane_NN along_IN a_DT hydrophobic_JJ core_NN ,_, thereby_RB allowing_VBG an_DT en_FW face_NN view_NN of_IN the_DT strands_NNS of_IN the_DT TJ_NP ._SENT Electron_NP micrographs_NNS of_IN freeze-fracture_NN replicas_NNS from_IN non-CF_NN cultures_NNS treated_VBN with_IN TNF-alpha_NP and_CC IFN-gamma_NP for_IN 72_CD h_NN revealed_VBD that_IN treatment_NN decreased_VBD overall_JJ junctional_JJ depth_NN and_CC number_NN of_IN strands_NNS (_( Figure_NP ,_, A_NP and_CC C_NP )_) ._SENT In_IN cultures_NNS exposed_VBN to_TO cytokines_NNS ,_, junctional_JJ depth_NN was_VBD measured_VBN at_IN 0.295_CD +-_NN 0.020_CD mum_NN ,_, whereas_IN that_IN of_IN vehicle_NN controls_NNS was_VBD 0.469_CD +-_NN 0.103_CD mum_NN as_IN determined_VBN by_IN morphometric_JJ analysis_NN (_( Figure_NP C_NP )_) ._SENT Strand_NP number_NN was_VBD decreased_VBN from_IN 6.90_CD +-_NN 0.372_CD in_IN vehicle_NN controls_NNS to_TO 4.85_CD +-_NN 0.214_CD in_IN cultures_NNS exposed_VBN to_TO TNF-alpha_NP and_CC IFN-gamma_NP ._SENT Figure_NP 4_CD |_SYM Morphology_NN of_IN TJs_NP of_IN primary_JJ HAE_NP cells_NNS exposed_VBN to_TO TNF-alpha_NP and_CC IFN-gamma_NP ._SENT Morphology_NN of_IN TJs_NP of_IN primary_JJ HAE_NP cells_NNS exposed_VBN to_TO TNF-alpha_NP and_CC IFN-gamma_NP ._SENT Freeze-fracture_NN analysis_NN of_IN TJ_NP strands_NNS of_IN WD_NP non-CF_NP (_( A_NP )_) or_CC CF_NP (_( B_NP )_) HAE_NP cells_NNS exposed_VBN to_TO vehicle_NN or_CC cytokines_NNS for_IN the_DT indicated_JJ times_NNS ._SENT (_( C_NP )_) Quantification_NN of_IN strand_NN number_NN and_CC depth_NN ._SENT Micrographs_NNS are_VBP representative_JJ of_IN 40_CD mum_NN (_( vehicle_NN non-CF_NN )_) ,_, 20_CD mum_NN (_( vehicle_NN CF_NP )_) ,_, 70_CD mum_NN (_( non-CF_NN 72_CD h_NN )_) ,_, 60_CD mum_NN (_( CF_NP 24_CD h_NN )_) ,_, and_CC 50_CD mum_NN (_( CF_NP 72_CD h_NN )_) of_IN TJ_NP analyzed_VBD ._SENT Significantly_RB different_JJ from_IN vehicle_NN controls_NNS (_( *_SYM )_) ,_, vehicle_NN controls_NNS and_CC 24_CD h_NN exposure_NN (_( **_SYM )_) ,_, and_CC from_IN non-CF_NP 72_CD h_NN at_IN p_NN <_SYM 0.05_CD ._SENT Unlike_IN non-CF_NN cultures_NNS ,_, which_WDT were_VBD unaffected_JJ by_IN cytokines_NNS at_IN 24_CD h_NN ,_, the_DT effect_NN of_IN TNF-alpha_NP and_CC IFN-gamma_NP on_IN RT_NP of_IN CF_NP cultures_NNS was_VBD pronounced_VBN by_IN 24_CD h_NN after_IN treatment_NN (_( Figure_NP C_NP )_) ._SENT For_IN this_DT reason_NN ,_, freeze-fracture_NN analysis_NN was_VBD also_RB performed_VBN on_IN CF_NP cultures_NNS at_IN 24_CD h._NN After_IN exposure_NN for_IN 24_CD h_NN ,_, CF_NP cultures_NNS displayed_VBD a_DT significant_JJ change_NN in_IN both_DT depth_NN and_CC strand_NN number_NN ,_, with_IN changes_NNS similar_JJ to_TO those_DT seen_VBN in_IN non-CF_NN cultures_NNS after_IN 72_CD h_NN cytokine_NN exposure_NN (_( Figure_NP B_NP )_) ._SENT By_IN 72_CD h_NN ,_, the_DT number_NN of_IN strands_NNS had_VBD decreased_VBN to_TO 1.97_CD +-_NN 0.214_CD and_CC junctional_JJ depth_NN to_TO 0.068_CD +-_NN 0.007_CD mum_NN ,_, compared_VBN with_IN a_DT strand_NN number_NN of_IN 6.7_CD +-_NN 0.227_CD and_CC a_DT depth_NN of_IN 0.501_CD +-_NN 0.170_CD mum_NN in_IN vehicle-controls_NNS ._SENT Although_IN the_DT RT_NP and_CC Papp_NP of_IN CF_NP cultures_NNS at_IN 72_CD h_NN after_IN cytokine_NN exposure_NN do_VBP not_RB differ_VB significantly_RB from_IN non-CF_NN ,_, TJ_NP morphology_NN differs_VBZ significantly_RB ,_, suggesting_VBG an_DT increased_VBN sensitivity_NN of_IN CF_NP cultures_NNS to_TO TNF-alpha_NP and_CC IFN-gamma_NP ._SENT Cytokine_NN Effects_NNS on_IN the_DT Integrity_NN of_IN TJ-Associated_NP Proteins_NPS |_SYM To_TO determine_VB whether_IN exposure_NN to_TO TNF-alpha_NP and_CC IFN-gamma_NP disrupted_VBD the_DT organization_NN of_IN TJ-associated_JJ proteins_NNS ,_, we_PP performed_VBD immunofluorescence_NN localization_NN of_IN ZO-1_NP ,_, JAM_NP ,_, claudin-1_JJ ,_, claudin-4_JJ ,_, and_CC occludin_NN ._SENT When_WRB double-immunofluorescence_NN localization_NN was_VBD performed_VBN for_IN the_DT cytoplasmic_JJ protein_NN ZO-1_NP and_CC the_DT integral_JJ membrane_NN protein_NN JAM_NP ,_, we_PP saw_VBD redistribution_NN of_IN both_DT proteins_NNS at_IN 48_CD h_NN and_CC 72_CD h_NN (_( Figure_NP A_NP )_) ,_, with_IN less_JJR obvious_JJ alterations_NNS at_IN 24_CD h_NN (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT apparent_JJ disruption_NN was_VBD detected_VBN only_RB in_IN cultures_NNS treated_VBN with_IN the_DT combination_NN of_IN TNF-alpha_NP and_CC IFN-gamma_NP and_CC not_RB in_IN cultures_NNS treated_VBN with_IN IL-1beta_NP ,_, TNF-alpha_NP ,_, or_CC IFN-gamma_NP alone_RB (_( data_NNS not_RB shown_VBN )_) ._SENT CF_NP cultures_NNS at_IN 24_CD h_NN exposure_NN to_TO TNF-alpha_NP and_CC IFN-gamma_NP exhibited_VBD a_DT similar_JJ pattern_NN of_IN reorganization_NN of_IN ZO-1_NP and_CC JAM_NP as_IN non-CF_NN cultures_NNS at_IN 72_CD h_NN (_( Figure_NP A_NP )_) ._SENT CF_NP cultures_NNS exposed_VBN to_TO cytokines_NNS for_IN 72_CD h_NN displayed_VBD a_DT similar_JJ relocalization_NN of_IN ZO-1_NP and_CC JAM_NP as_IN non-CF_NP at_IN 72_CD h_NN (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT apparent_JJ change_NN in_IN localization_NN of_IN ZO-1_NP and_CC JAM_NP shown_VBN by_IN immunofluorescence_NN was_VBD also_RB associated_VBN with_IN a_DT decrease_NN in_IN ZO-1_NP and_CC JAM_NP expression_NN by_IN Western_JJ blot_NN analysis_NN of_IN non-CF_NN cultures_NNS exposed_VBN to_TO TNF-alpha_NP and_CC IFN-gamma_NP for_IN 72_CD h_NN (_( Figure_NP B_NP )_) ._SENT Figure_NP 5_CD |_SYM Effect_NN of_IN TNF-alpha_NP and_CC IFN-gamma_NP treatment_NN on_IN expression_NN and_CC localization_NN of_IN JAM_NP and_CC ZO-1_NP ._SENT Effect_NN of_IN TNF-alpha_NP and_CC IFN-gamma_NP treatment_NN on_IN expression_NN and_CC localization_NN of_IN JAM_NP and_CC ZO-1_NP ._SENT (_( A_NP )_) Immunofluorescent_NN staining_VBG for_IN JAM_NP and_CC ZO-1_NP in_IN non-CF_NP and_CC CF_NP primary_JJ HAE_NP cells_NNS exposed_VBN to_TO TNF-alpha_NP and_CC IFN-gamma_NP for_IN 72_CD or_CC 24_CD h._JJ Red_NP staining_VBG (_( left_NN )_) represents_VBZ ZO-1_JJ ,_, green_JJ staining_VBG (_( middle_NN )_) is_VBZ JAM_NP ,_, and_CC (_( right_JJ )_) merged_JJ image_NN of_IN both_DT ZO-1_NP and_CC JAM_NP ._SENT Areas_NNS of_IN colocalization_NN appear_VBP as_RB yellow_JJ ._SENT Images_NNS are_VBP representative_JJ of_IN a_DT minimum_NN of_IN n_NN =_SYM 6_CD cultures_NNS from_IN two_CD patients_NNS ._SENT (_( B_LS )_) Western_JJ blotting_VBG of_IN ZO-1_NP (_( top_NN )_) and_CC immunoprecipitation_NN of_IN JAM_NP (_( middle_NN )_) in_IN non-CF_NN cultures_NNS ._SENT Western_JJ blot_NN for_IN ZO-1_NP was_VBD stripped_VBN and_CC reprobed_VBN with_IN an_DT antibody_NN specific_JJ for_IN claudin-1_JJ to_TO control_VB for_IN loading_NN (_( bottom_NN )_) ._SENT However_RB ,_, immunofluorescence_NN localization_NN of_IN claudin-1_JJ showed_VBD no_DT apparent_JJ change_NN in_IN either_CC the_DT intensity_NN or_CC distribution_NN of_IN fluorescent_JJ staining_VBG for_IN either_DT protein_NN (_( Figure_NP A_NP )_) ._SENT Occludin_NN exists_VBZ in_IN both_CC a_DT high-molecular-weight_NN (_( HMW_NP )_) and_CC low-molecular-weight_NP (_( LMW_NP )_) form_NN ._SENT Although_IN immunofluorescence_NN did_VBD not_RB reveal_VB a_DT change_NN in_IN the_DT expression_NN or_CC localization_NN of_IN occludin_NN ,_, the_DT antibody_NN used_VBD recognized_VBN only_RB the_DT LMW_JJ form_NN of_IN the_DT protein_NN (_( Figure_NP A_NP )_) ._SENT To_TO reconcile_VB whether_IN there_EX were_VBD TNF-alpha_NP and_CC IFN-gamma_NP --_: induced_VBN effects_NNS on_IN either_DT occludin_NN expression_NN or_CC phosphorylation_NN ,_, we_PP performed_VBD Western_JJ blots_NNS with_IN two_CD antibodies_NNS ,_, one_CD recognizing_VBG only_RB the_DT LMW_NN and_CC one_CD recognizing_VBG both_DT forms_NNS ._SENT Samples_NNS isolated_VBN from_IN cultures_NNS exposed_VBN to_TO TNF-alpha_NP and_CC IFN-gamma_NP for_IN 72_CD h_NN and_CC probed_VBN with_IN an_DT antibody_NN recognizing_VBG both_CC the_DT LMW_NP and_CC HMW_NP forms_NNS appeared_VBD to_TO express_VB more_JJR of_IN the_DT 73-kDa_NP occludin_NN than_IN vehicle-controls_NNS (_( Figure_NP B_NP ,_, lanes_NNS 4_CD --_: 6_CD )_) ._SENT However_RB ,_, when_WRB the_DT membrane_NN was_VBD reprobed_VBN with_IN an_DT antibody_NN that_WDT recognizes_VBZ only_RB the_DT LMW_JJ form_NN of_IN the_DT protein_NN ,_, there_EX was_VBD no_DT change_NN in_IN the_DT 65-kDa_JJ occludin_NN band_NN after_IN treatment_NN (_( Figure_NP C_NP )_) ._SENT This_DT finding_NN would_MD indicate_VB that_IN the_DT relative_JJ increase_NN seen_VBN correlates_NNS 